This study analyzes whether dairy supplementation positively impacts loading exercise-induced bone cell activity and inflammation in healthy young females.
Introduction: Two million individuals at a cost of around 2.3 billion dollars a year in Canada suffer from osteoporosis. Research that emphasizes the treatment of this disease is important, but so is research that focuses on prevention; reducing bone loss and/or increasing bone mass when young. In addition, inflammation is an issue as it strongly relates to chronic disease. Countermeasures to improve bone health and inflammation, such as nutrition and exercise, should be explored and implemented. The proposed research combines both nutrition and exercise along with the assessment of bone turnover markers and inflammation in healthy young females, and aims to determine whether dairy versus a carbohydrate-based beverage positively impacts acute bone turnover and the inflammatory response following a bout of resistance and plyometric exercise. Design: Randomized controlled crossover trial. Participants: 13 healthy university aged females. Methods: Participants were asked to complete 2 different acute exercise and nutritional supplement trials. Each trial will be assigned in random order. The two trials were: 1) exercise+carbohydrate (CHO), and 2) exercise+milk (Milk). The whole study, per participant, took a maximum of 8-12 weeks to complete as each supplement trial was separated by \~4 weeks. Each treatment is outlined below. \*\*\*\*\*\*DUE TO COVID-19, we removed the treatment trial which involved milk+creatine supplementation. Despite randomization, and before the trial was closed, only 11 participants completed this trial\*\*\*\*\*\*\*\* Anticipated Results: The investigators anticipate that dairy and exercise will have a greater positive impact on acute bone cell activity and inflammation in healthy young females compared to exercise and CHO.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
13
A single resistance and plyometric exercise bout per trial.
50 grams immediately after exercise bout. 50 grams 1 hour after exercise bout.
500 ml immediately after exercise bout. 500 ml 1 hour after exercise bout.
York University
Toronto, Ontario, Canada
Acute Bone Cell Activity
Bone markers (OPG, RANKL, OC) measured in serum/plasma.
Time frame: Baseline
Acute Bone Cell Activity
Bone markers (SOST) measured in serum/plasma.
Time frame: Baseline
Acute Bone Cell Activity
Bone markers (CTX) measured in serum/plasma.
Time frame: Baseline
Acute Bone Cell Activity
Bone markers (OPG, RANKL, OC) measured in serum/plasma.
Time frame: 5 minutes post exercise
Acute Bone Cell Activity
Bone markers (SOST) measured in serum/plasma.
Time frame: 5 minutes post exercise
Acute Bone Cell Activity
Bone markers (CTX) measured in serum/plasma.
Time frame: 5 minutes post exercise
Acute Bone Cell Activity
Bone markers (OPG, RANKL, OC) measured in serum/plasma.
Time frame: 1 hour post exercise
Acute Bone Cell Activity
Bone markers (SOST) measured in serum/plasma.
Time frame: 1 hour post exercise
Acute Bone Cell Activity
Bone markers (CTX) measured in serum/plasma.
Time frame: 1 hour post exercise
Acute Bone Cell Activity
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Bone markers (OPG, RANKL, OC) measured in serum/plasma.
Time frame: 24 hours post exercise
Acute Bone Cell Activity
Bone markers (SOST) measured in serum/plasma.
Time frame: 24 hours post exercise
Acute Bone Cell Activity
Bone markers (CTX) measured in serum/plasma.
Time frame: 24 hours post exercise
Acute Bone Cell Activity
Bone markers (OPG, RANKL, OC) measured in serum/plasma.
Time frame: 48 hours post exercise
Acute Bone Cell Activity
Bone markers (SOST) measured in serum/plasma.
Time frame: 48 hours post exercise
Acute Bone Cell Activity
Bone markers (CTX) measured in serum/plasma.
Time frame: 48 hours post exercise